Electra City Tower
58 Harakevet St.
Tel Aviv
6777016
Ken Shaked
Ken has over 30 years' experience in providing ongoing legal services to corporates and commercial entities.
Thanks to his many years of activity in business development, management of startup companies, and investment in corporations, Ken supports entrepreneurs and startups from the project launch phase through to the exit phase.
In the course of this activity, Ken advises on issues related to setting up companies and raising funds for their activities. He also counsels on ongoing commercial issues, including licensing and intellectual property, distribution and cooperation agreements, research and development agreements, regulation, and more. Ken’s clients operate in a range of high-tech fields, with an emphasis on pharma, biotechnology, medical equipment, and cleantech.
Ken has served as in-house counsel for leading companies, including El-Al and Dexcel Pharma. He has also worked and served as a partner for a number of leading law firms.
Prominent legal directory The Legal 500 ranks Ken as a Recommended Lawyer in Commercial, Corporate and M&A, Hi-Tech and Start-Ups, Intellectual property: Commercial/Transactions
In addition, Ken managed various startups in the course of his role as vice president of Yissum Research Development Company of the Hebrew University, as well as CEO of various companies in the areas of cleantech, biotechnology, and medical equipment.
Education:
Tel Aviv University, LL.B., 1991
Haifa University, MBA, 2004
Admission:
Israel Bar Association, 1991
Insights & News - Ken Shaked:
Key Issues Shaping Israel’s Technology Sector in 2025 and Insights for 2026
2025 was characterized by an acceleration of technological regulatory trends that directly impacted the work of commercial lawyers and corporate decision-making. Amid geopolitical tensions, pressure on public systems, volatile markets, and maturing AI technologies, the corporate playing field became even more complex: regulation, taxation, intellectual property, collaborations with state entities, and transaction structures all demanded renewed scrutiny.
Legal Obligations for Recipients of Israel Innovation Authority Grants
Securing a grant from the Israel Innovation Authority (IIA) is a major vote of confidence and a critical financial boost for any R&D company. However, the funding comes with a complex set of legal, regulatory, and financial obligations that startup founders must rigorously adhere to. Failure to comply can result in grant revocation, financial penalties, or the required repayment of funds. In this update, you will find a comprehensive overview of the principal duties and restrictions imposed on IIA grant recipients.